COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,157 Articles (22,703 medRxiv, 8,454 bioRxiv)

Most recent first Previous |  Page 1943: Articles 19421-19430  | Next

Development and external validation of a logistic regression derived formula based on repeated routine hematological measurements predicting survival of hospitalized Covid-19 patients
Heber, S., Pereyra, D., Schrottmaier, W., Kammerer, K., Santol, J., Pawelka, E., Hana, M., Scholz, A., Liu, M., Hell, A., Heiplik, K., Lickefett, B., Haverall, S., Traugott, M., Neuboeck, M., Schoergenhofer, C., Seitz, T., Firbas, C., Karolyi, M., Weiss, G., Jilma, B., Thalin, C., Bellmann-Weiler, R., Salzer, H., Fischer, M. J., Zoufaly, A., Assinger, A.
10.1101/2020.12.20.20248563 — Posted: 2020-12-22
A Working Model to Inform Risk-Based Back to Work Strategies
Meier, K., Curnow, K. J., Vavrek, D., Moon, J., Farh, K., Chian, M., Ragusa, R., de Feo, E., Febbo, P. G.
10.1101/2020.12.18.20248512 — Posted: 2020-12-22
A DNA INTERCALATING DYE-BASED RT-QPCR ALTERNATIVE TO DIAGNOSE SARS-COV-2
Fuchs Wightman, F., Godoy Herz, M., Munoz, J. C., Stigliano, J. N., Bragado, L., Nieto Moreno, N., Palavecino, M., Servi, L., Cabrerizo, G., Clemente, J., Avaro, M., Pontoriero, A., Benedetti, E., Baumeister, E., Rudolf, F., Remes Lenicov, F., COVID-19-INBIRS working group, , Garcia, C., Buggiano, V., Kornblihtt, A. R., Srebrow, A., de la Mata, M., Munoz, M. J., Schor, I. E., Petrillo, E.
10.1101/2020.12.16.20246678 — Posted: 2020-12-22 Discussion: Onsite
Prioritizing Risk Groups for SARS-CoV-2 Vaccination "By the Numbers"
McDonald, C. J., Baik, S. H., Zheng, Z., Amos, L.
10.1101/2020.12.18.20248504 — Posted: 2020-12-22
Social disparities in the first wave of COVID-19 infections in Germany: A county-scale explainable machine learning approach
Doblhammer, G., Reinke, C., Kreft, D.
10.1101/2020.12.22.20248386 — Posted: 2020-12-22
Several forms of SARS-CoV-2 RNA can be detected in wastewaters : implication for wastewater-based epidemiology and risk assessment.
Wurtzer, S., Waldman, P., Ferrier-Rembert, A., Frenois-Veyrat, G., Mouchel, J.-M., Boni, M., Maday, Y., Obepine, C., Marechal, V., Moulin, L.
10.1101/2020.12.19.20248508 — Posted: 2020-12-22
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms
Wagner, A., Guzek, A., Ruff, J., Jasinska, J., Scheikl, U., Zwazl, I., Kundi, M., Stockinger, H., Farcet, M. R., Kreil, T., Hoeltl, E., Wiedermann, U.
10.1101/2020.12.22.20248604 — Posted: 2020-12-22
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school-children: prospective cohort study of 55 schools in Switzerland
Ulyte, A., Radtke, T., Abela, I. A., Haile, S. R., Berger, C., Huber, M., Schanz, M., Schwarzmueller, M., Trkola, A., Fehr, J., Puhan, M. A., Kriemler, S.
10.1101/2020.12.19.20248513 — Posted: 2020-12-22 Discussion: Onsite
Projecting the combined healthcare burden of seasonal influenza and COVID-19
Du, Z., Fox, S. J., Ingle, T., Pignone, M. P., Meyers, L. A.
10.1101/2020.12.20.20248599 — Posted: 2020-12-22
SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19.
Ram-Mohan, N., Kim, D., Zudock, E. J., Hashemi, M. M., Tjandra, K. C., Rogers, A. J., Blish, C. A., Nadeau, K. C., Newberry, J. A., Quinn, J. V., O'Hara, R., Ashley, E., Nguyen, H., Jiang, L., Hung, P., the Stanford COVID-19 Biobank Study Group, , Blomkalns, A. L., Yang, S.
10.1101/2020.12.19.20248561 — Posted: 2020-12-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).